LBA-1 Rivaroxaban Thromboprophylaxis in High-Risk Ambulatory Cancer Patients Receiving Systemic Therapy: Results of a Randomized…
Tag:
Nuovi anticoagulanti orali
-
-
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer Carrier M, Abou-Nassar K, Mallick R,…
-
Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT):…
-
American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and…
-
Position paper ANMCO: Uso dei nuovi anticoagulanti orali nella terapia e nella prevenzione della tromboembolia…
-
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical…